Switching to quetiapine in patients with acute mania who were intolerant to risperidone

Human Psychopharmacology

Volumn 19, Issue 1, 2004, Pages 47-51

  Pae, Chi Un ^a   Lee, Kyong Uk ^a   Kim, Jung Jin ^a   Lee, Chang Uk ^a   Bahk, Won Myong ^a   Lee, Soo Jung ^a   Lee, Chul ^a   Paik, In Ho ^a  

^a The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

Mania; Quetiapine; Risperidone; Switch

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BENZATROPINE; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CHLORPROMAZINE; LITHIUM; LORAZEPAM; QUETIAPINE; RISPERIDONE; VALPROIC ACID;

ACUTE DISEASE; ADULT; AKATHISIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERABILITY; DYSTONIA; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEALTH BEHAVIOR; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; MALE; MANIA; MEASUREMENT; MENTAL DISEASE; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SEDATION; SIDE EFFECT; SOMNOLENCE; TREATMENT OUTCOME; XEROSTOMIA;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DIBENZOTHIAZEPINES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; RISPERIDONE; TREATMENT OUTCOME;

EID: 0742324803     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/hup.549     Document Type: Article

References (22)

1. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorder, 4th edn (DSM-IV). American Psychiatric Press: Washington, DC.
2. Barnes TR. 1989. A rating scale for drug-induced akathisia. Br J Psychiatry 154: 672-676.
3. Brambilla P, Barale F, Soares JC. 2003. Atypical antipsychotics and mood stabilization in bipolar disorder. Psychopharmacology (Berl) 166: 315-332.
4. Brown ES, Nejtek VA, Perantie DC, Bobadilla L. 2002. Quetiapine in bipolar disorder and cocaine dependence. Bipolar Disord 4: 406-411.
5. Delbello MP, Schwiers ML, Rosenberg HL, Strakowski SM. 2002. A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry 41: 1216-1223.
6. Guy W. 1976. ECDEU Assessment Manual for Psychopharmacology, revised. DHEW Pub. No. (ADM) 76-338. National Institute of Mental Health: Rockville, MD.
7. Hogan TP, Awad AG, Eastwood R. 1983. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med 13: 177-183.
8. Jacobsen FM. 1995. Risperidone in the treatment of affective illness and obsessive-compulsive disorder. J Clin Psychiatry 56: 423-429.
9. Lerer B, Segman RH, Fangerau H, et al. 2002. Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism. Neuropsychopharmacology 27: 105-119.
10. Licht RW, Bysted M, Christensen H. 2001. Fixed-dosed risperidone in mania: an open experimental trial. Int Clin Psychopharmacol 16: 103-110.
11. Prior TI, Baker GB. 2003. Interactions between the cytochrome P450 system and the second-generation antipsychotics. J Psychiatry Neurosci 28: 99-112.
12. Sachs GS, Grossman F, Ghaemi SN, Okamoto A, Bowden CL. 2002. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry 159: 1146-1154.
13. Sajatovic M, Brescan DW, Perez DE, et al. 2001. Quetiapine alone and added to a mood stabilizer for serious mood disorders. J Clin Psychiatry 62: 728-732.
14. Sajatovic M, DiGiovanni SK, Bastani B, Hattab H, Ramirez LF. 1996. Risperidone therapy in treatment refractory acute bipolar and schizoaffective mania. Psychopharmacol Bull 32: 55-61.
15. Segal J, Berk M, Brook S. 1998. Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial. Clin Neuropharmacol 21: 176-180.
16. Sheehan DV, Lecrubier Y, Sheehan KH, et al. 1998. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(Suppl. 20): 22-33.
17. Simpson GM, Angus JW. 1970. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand (Suppl.) 212: 11-19.
18. Vieta E, Herraiz M, Parramon G, Goikolea JM, Fernandez A, Benabarre A. 2002a. Risperidone in the treatment of mania: efficacy and safety results from a large, multicentre, open study in Spain. J Affect Disord 72: 15-19.
19. Vieta E, Parramon G, Padrell E, et al. 2002b. Quetiapine in the treatment of rapid cycling bipolar disorder. Bipolar Disord 4: 335-340.
20. Yatham LN, Binder C, Riccardelli R, et al. 2003a. Risperidone in acute and continuation treatment of mania. Int Clin Psychopharmacol 18: 227-235.
21. Yatham LN, Grossman F, Augustyns I, Vieta E, Ravindran A. 2003b. Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial. Br J Psychiatry 182: 141-147.
22. Young RC, Biggs JT, Ziegler VE, Meyer DA. 1978. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133: 429-435.